GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab


You May Also Like

Dermira Elects Emmanuel Caeymaex to Board of Directors

MENLO PARK, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical ...

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...